PCF TACTICAL Awards
Supports for team-of-teams projects on lethal prostate cancer therapies program.
PCF TACTICAL Awards are the foundation's largest grants, providing $5M–$10M per award over 3–5 years for development of 21st-century therapies for lethal forms of prostate cancer. The program uses a 'team of teams' model — multiple investigator groups working in coordinated fashion toward ambitious translational goals. The 2026 cycle included an LOI deadline of March 16, 2026. Projects must be high-risk and currently unfunded by other sources.
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.